General medical aspects of the use of meloxicam (Movalis®) in clinical practice: Efficacy and safety

Abstract

The paper gives the results of randomized clinical trials and the use of meloxicam in real clinical practice in patients having risk factors for unfavorable gastrointestinal and cardiovascular events. It shows the advantages of meloxicam in safety and equal efficacy as compared with those of nonselective nonsteroidal anti-inflammatory drugs, and its high safety in causing gastrointestinal complications, which is highly competitive with that of celecoxib. Clinical and experimental findings suggesting that meloxicam has no negative effect on the cartilage are presented.

Keywords

• meloxicam (Movalis®)
• efficacy
• safety
• rheumatic diseases